Drew Moghanaki
@drewmoghanaki
MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles
ID: 1322269645
https://www.uclahealth.org/radonc/drew-moghanaki 02-04-2013 11:09:53
23,23K Tweet
12,12K Followers
1,1K Following
New data from the randomized PEMBRO-RT study demonstrate when an ICI-mediated Abscopal effect is most likely to occur in patients with stage IV NSCLC. Ralph Weichselbaum Sean Pitroda, M.D. Amy L. Cummings, MD PhD doi.org/10.1038/s43018…
